Successful shunt closure and improvement of hemodynamics in an ASD patient with severe pulmonary arterial hypertension and small shunt following a long-term use of bosentan

被引：8
|
作者：
Tahara, Nobuhiro [1 ]
Mizoguchi, Minori [1 ]
Honda, Akihiro [1 ]
Tahara, Atsuko [1 ]
Nitta, Yoshikazu [1 ]
Kodama, Norihiro [1 ]
Koiwaya, Hiroshi [1 ]
Aoyagi, Shigeaki [2 ]
Imaizumi, Tsutomu [1 ]
机构：
[1] Kurume Univ, Sch Med, Dept Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan
[2] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2012年 / 158卷 / 02期
关键词：
Pulmonary arterial hypertension; Atrial septal defect; Bosentan; SEPTAL-DEFECT CLOSURE; THERAPY; EPOPROSTENOL;
D O I：
10.1016/j.ijcard.2011.10.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E38 / E40
页数：3
相关论文
共 50 条
  • [21] Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension
    Kim, NH
    Channick, RN
    Rubin, LJ
    CHEST, 2003, 124 (04) : 1612 - 1615
  • [22] Transcatheter creation of a reverse Potts shunt in a patient with severe pulmonary arterial hypertension associated with Moyamoya syndrome
    Schranz, Dietmar
    Kerst, Gunter
    Menges, Thilo
    Akintuerk, Hakan
    van Alversleben, Inge
    Ostermayer, Stefan
    Apitz, Christian
    Moysich, Axel
    EUROINTERVENTION, 2015, 11 (01) : 121 - 121
  • [23] Long Term Use Of Imatinib In Patients With Severe Pulmonary Arterial Hypertension
    Ghofrani, H. A.
    Morrell, N. W.
    Hoeper, M. M.
    Olschewski, H.
    Peacock, A.
    Barst, R. J.
    Shapiro, S.
    Quinn, D. A.
    Pascoe, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [24] Long-term bosentan therapy improves exercise capacity and hemodynamics in sarcoidosis-associated pulmonary hypertension
    Qua, Debbie
    Palmero, Veronica
    Sulica, Roxana
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [25] Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
    Provencher, S
    Sitbon, O
    Humbert, M
    Cabrol, S
    Jaïs, X
    Simonneau, G
    EUROPEAN HEART JOURNAL, 2006, 27 (05) : 589 - 595
  • [26] Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension - Long-term efficacy and combination with bosentan
    Benza, Raymond L.
    Rayburn, Barry K.
    Tallaj, Jose A.
    Pamboukian, Salpy V.
    Bourge, Robert C.
    CHEST, 2008, 134 (01) : 139 - 145
  • [27] Acute and long-term results of ASD II catheter closure in patients with pulmonary hypertension.
    Reschke, M
    Hofmann, I
    Bayard, Y
    Römer, A
    Buescheck, F
    Ostermayer, S
    Trepels, T
    Middeldorf, T
    Jensen, HL
    Billinger, K
    Hein, R
    Taaffe, MJ
    Lang, K
    Wilson, N
    Sievert, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 30E - 31E
  • [28] Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension
    Speich, Rudolf
    Treder, Ursula
    Domenighetti, Guido
    Huber, Lars C.
    Ulrich, Silvia
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (02) : 256 - 260
  • [29] Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension
    Rudolf Speich
    Ursula Treder
    Guido Domenighetti
    Lars C. Huber
    Silvia Ulrich
    International Journal of Clinical Pharmacy, 2014, 36 : 256 - 260
  • [30] Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reportsStrategy for ASD with Severe PAH
    Yu Taniguchi
    Noriaki Emoto
    Kazuya Miyagawa
    Kazuhiko Nakayama
    Hiroto Kinutani
    Hidekazu Tanaka
    Toshiro Shinke
    Kenji Okada
    Yutaka Okita
    Ken-ich Hirata
    Heart and Vessels, 2014, 29 : 282 - 285
12345